Henshaw Capital’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-7,066
| Closed | -$906K | – | 263 |
|
|
2025
Q2 | $906K | Sell |
7,066
-1,409
| -17% | -$146K | 0.04% | 165 |
|
|
2025
Q1 | $750K | Hold |
8,475
| – | – | 0.03% | 170 |
|
|
2024
Q4 | $739K | Hold |
8,475
| – | – | 0.03% | 153 |
|
|
2024
Q3 | $784K | Hold |
8,475
| – | – | 0.03% | 160 |
|
|
2024
Q2 | $913K | Buy |
8,475
+134
| +2% | +$13.4K | 0.04% | 118 |
|
|
2024
Q1 | $791K | Sell |
8,341
-1,547
| -16% | -$133K | 0.04% | 127 |
|
|
2023
Q4 | $912K | Sell |
9,888
-223
| -2% | -$14.4K | 0.05% | 117 |
|
|
2023
Q3 | $508K | Buy |
10,111
+3,860
| +62% | +$206K | 0.03% | 153 |
|
|
2023
Q2 | $395K | Buy |
6,251
+602
| +11% | +$32.7K | 0.02% | 147 |
|
|
2023
Q1 | $254K | Hold |
5,649
| – | – | 0.02% | 198 |
|
|
2022
Q4 | $247K | Buy |
5,649
+841
| +17% | +$40.3K | 0.02% | 200 |
|
|
2022
Q3 | $317K | Hold |
4,808
| – | – | 0.02% | 196 |
|
|
2022
Q2 | $243K | Hold |
4,808
| – | – | 0.02% | 257 |
|
|
2022
Q1 | $307K | Hold |
4,808
| – | – | 0.02% | 244 |
|
|
2021
Q4 | $515K | Hold |
4,808
| – | – | 0.03% | 169 |
|
|
2021
Q3 | $494K | Hold |
4,808
| – | – | 0.03% | 166 |
|
|
2021
Q2 | $423K | Buy |
4,808
+1,052
| +28% | +$96.4K | 0.03% | 198 |
|
|
2021
Q1 | $365K | Buy |
3,756
+555
| +17% | +$55.4K | 0.02% | 222 |
|
|
2020
Q4 | $359K | Buy |
3,201
+641
| +25% | +$67.6K | 0.03% | 218 |
|
|
2020
Q3 | $237K | Buy |
+2,560
| New | +$197K | 0.02% | 273 |
|
Other funds holding BPMC
IA
HNB